APOE and Alzheimer disease: This likely reflects the fact that individuals at greater genetic risk (i.e., APOE-ε4 carriers; higher AD-PRS scores) have more AD pathology (e.g., [11, 64–66]) which at least partially underlies the relationship between these genetic risk factors and cognitive decline [63, 67, 68].